Top Markets
#1 B3 (Base) B3 (Base) +68.61%
#2 Chainbase Chainbase +49.84%
#3 Stargate Finance Stargate Finance +25.33%
#4 Kyber Network Crystal Kyber Network Crystal +23.06%
#5 Liquid Mercury Liquid Mercury +20.08%
#6 Block Street Block Street +16.15%
#7 Trusta AI Trusta AI +12.43%
#8 BabyBoomToken BabyBoomToken +11.40%
#9 PlaysOut PlaysOut +10.18%
#10 MEMEX Token MEMEX Token +9.89%
Coin of the day
B3 (Base) B3 (Base)
सेटिंग्स
भाषा
हिन्दी
मुद्रा
USD
थीम
Bristol-Myers Squibb Company Bristol-Myers Squibb Company

Bristol-Myers Squibb Company

BMY
शेयरों में रैंक #149
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and... Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; Opdivo for anti-cancer indications; Pomalyst/Imnovid indicated for patients with multiple myeloma; and Orencia for adult patients with active RA and psoriatic arthritis. It also provides Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Abraxane, a protein-bound chemotherapy product; Reblozyl for the treatment of anemia in adult patients with beta thalassemia; and Empliciti for the treatment of multiple myeloma. In addition, the company offers Zeposia to treat relapsing forms of multiple sclerosis; Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma; Inrebic, an oral kinase inhibitor indicated for the treatment of adult patients with myelofibrosis; and Onureg for the treatment of adult patients with AML. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in New York, New York.
शेयर मूल्य
$59.43
मार्केट कैप
$121.03B
बदलाव (1 दिन)
0.83%
बदलाव (1 वर्ष)
0.90%
देश
US
व्यापार Bristol-Myers Squibb Company (BMY)

श्रेणी

Healthcare
Bristol-Myers Squibb Company (BMY) के लिए P/B अनुपात
March 2026 को P/B अनुपात TTM: 6.53
Bristol-Myers Squibb Company की नवीनतम वित्तीय रिपोर्ट और शेयर मूल्य के अनुसार, कंपनी का वर्तमान P/B अनुपात (TTM) 6.53 है। 2024 के अंत में, कंपनी का P/B अनुपात 7.02 था।
Bristol-Myers Squibb Company के लिए 2000 से 2026 तक P/B अनुपात का इतिहास
हर वर्ष के अंत में P/B अनुपात
वर्ष P/B अनुपात परिवर्तन
2026 (TTM) 6.53 -100.00%
2025 0.00 -100.00%
2024 7.02 94.57%
2023 3.61 -26.89%
2022 4.93 28.08%
2021 3.85 4.03%
2020 3.70 74.59%
2019 2.12 -64.94%
2018 6.05 -29.54%
2017 8.59 42.23%
2016 6.04 -24.90%
2015 8.04 22.05%
2014 6.59 14.22%
2013 5.77 44.33%
2012 4.00 6.41%
2011 3.75 30.06%
2010 2.89 -14.03%
2009 3.36 -10.57%
2008 3.76 -24.09%
2007 4.95 -4.20%
2006 5.16 29.01%
2005 4.00 -17.94%
2004 4.88 -13.85%
2003 5.66 7.21%
2002 5.28 -51.57%
2001 10.90 -27.65%
2000 15.07 0.00%
समान कंपनियों या प्रतिस्पर्धियों के लिए P/B अनुपात
कंपनी P/B अनुपात P/B अनुपात में अंतर देश
Eli Lilly Eli Lilly
Eli Lilly
LLY.US
 33.3372 410.72%
US
AstraZeneca PLC AstraZeneca PLC
AstraZeneca PLC
AZN.US
 6.0657 -7.07%
GB
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 7.1931 10.20%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 -119.6075 -1,932.36%
US
Novartis AG Novartis AG
Novartis AG
NVS.US
 6.3334 -2.97%
CH